EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 157 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,564,000 | +18.2% | 59,189 | +127.8% | 0.01% | -21.4% |
| Q4 2021 | $1,323,000 | +21.5% | 25,979 | +2.1% | 0.01% | -12.5% |
| Q2 2021 | $1,089,000 | +106.2% | 25,434 | +101.2% | 0.02% | +77.8% |
| Q1 2021 | $528,000 | +1023.4% | 12,642 | +1144.3% | 0.01% | +800.0% |
| Q4 2020 | $47,000 | +23.7% | 1,016 | +14.9% | 0.00% | 0.0% |
| Q3 2020 | $38,000 | -56.3% | 884 | -47.0% | 0.00% | -50.0% |
| Q1 2020 | $87,000 | -74.6% | 1,669 | -70.8% | 0.00% | -86.7% |
| Q4 2019 | $343,000 | -5.5% | 5,709 | -11.0% | 0.02% | +87.5% |
| Q3 2019 | $363,000 | +20.6% | 6,418 | +18.7% | 0.01% | +14.3% |
| Q2 2019 | $301,000 | +30.9% | 5,408 | +18.8% | 0.01% | +16.7% |
| Q1 2019 | $230,000 | +39.4% | 4,551 | +91.1% | 0.01% | 0.0% |
| Q3 2018 | $165,000 | +153.8% | 2,382 | +175.4% | 0.01% | +100.0% |
| Q2 2018 | $65,000 | +242.1% | 865 | +139.0% | 0.00% | +200.0% |
| Q1 2018 | $19,000 | -75.3% | 362 | -74.9% | 0.00% | -80.0% |
| Q4 2017 | $77,000 | +156.7% | 1,444 | +190.5% | 0.01% | +66.7% |
| Q3 2017 | $30,000 | – | 497 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 475,755 | $25,068,000 | 24.71% |
| Hudson Executive Capital LP | 971,000 | $51,162,000 | 15.09% |
| Park West Asset Management LLC | 1,051,274 | $55,392,000 | 2.47% |
| U S GLOBAL INVESTORS INC | 19,200 | $1,012,000 | 0.62% |
| Capital Impact Advisors, LLC | 26,317 | $1,387,000 | 0.57% |
| CLARK ESTATES INC/NY | 56,278 | $2,965,000 | 0.47% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 873,131 | $46,005,000 | 0.41% |
| ProQuest Associates IV LLC | 6,777 | $357,000 | 0.41% |
| Granite Investment Partners, LLC | 114,207 | $6,017,000 | 0.40% |
| GLOBEFLEX CAPITAL L P | 30,900 | $1,628,000 | 0.34% |